A new study in rats shows that stem cell secretions called exosomes appear to protect cells in the retina, the light-sensitive tissue in the back of the eye.
You are here
Coverage of the latest news and updates from the field of stem cells.
Scientists at the Salk Institute were able to grow a rat pancreas as well as heart and eyes in a developing mouse, providing proof-of-concept that functional organs from one species can be grown in another.
Scientists have developed a prototype for a 3D bioprinter that can create totally functional human skin. This skin is adequate for transplanting to patients or for use in research or the testing of cosmetic, chemical and pharmaceutical products.
Scientists in the field of regenerative medicine have developed a set of ethical guidelines that they hope will become standard consideration for research into human organ models.
Researchers at Trinity College Dublin have made exciting new findings that could offer a means of fighting resistance to treatment for people with esophageal cancer. Resistance to radiotherapy is a major stumbling block in the treatment of this cancer.
Stem cells are among the most energetically activated, migratory and proliferative sub-populations of tumor cells, according to observations by scholars at the Biomedical Research Centre at the University of Salford.
A process using human stem cells can generate the cells that cover the external surface of a human heart — epicardium cells — according to a multidisciplinary team of researchers.
Bone fractures in diabetic mice heal better in the presence of a protein that stimulates the activity of skeletal stem cells, according to a study by researchers at the Stanford University School of Medicine.
Applications are due February 15 for the next round of the California Institute of Regenerative Medicine's (CIRM) Quest Awards (DISC 2), ranging from $700,000 to $1.4 million (US).
A simple injection of stem cells that could help kidney transplant patients avoid a lifetime on anti-rejection drugs was one of two new clinical trials approved recently by the governing board of the California Institute for Regenerative Medicine (CIRM).